ANDA 85299, held by Solvay. Quinidine Sulfate.
As of Nov 16, 2026, ANDA 85299 (Cin-Quin), held by Solvay, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Cin-Quin100MG ยท tablet;oral | Quinidine Sulfate | DiscontinuedReference drug |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters